Delivery Order SPE2DR25D1002-SPE2DR26FGN0F
Award Date 1/20/26
Potential Completion Date 1/21/26
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL dosage). This is a firm fixed-price delivery order with a ceiling value of $10,843.19 and an ultimate completion date of August 26, 2025. The award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,109.11 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Gvoke HypoPen 1-Pack 1 mg/0.2 mL auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 8, 2026. This delivery order is a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gvoke HypoPen 1-mg/0.2-ml auto-injector pens with a ceiling value of $1,057.60 under a firm fixed price contract type. The award was made on November 7, 2025, with an ultimate completion date of November 10, 2025. This is a non-set-aside competitively awarded order, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,117.88 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 mL) on January 8, 2026, with a completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,210.24 to AmerisourceBergen Drug Corp for GVOKE HypopenR 2-pack auto-injectors (1 mg/0.2 ml) on December 10, 2025, with completion scheduled for December 11, 2025. This competitive, non-set-aside award was structured as a firm fixed-price delivery order, with performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The product being delivered is a glucagon emergency treatment medication used for...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.18 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 ml) on November 5, 2025, with completion expected by November 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. GVOKE HypoPen is a glucagon auto-injector used for emergency treatment of severe hypoglycemia in patients with diabetes, making...
- The Defense Logistics Agency awarded a delivery order valued at $10,850.43 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 ml). This firm fixed-price, non-set-aside contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GVOKE HypoPen is an emergency glucagon auto-injector used to treat severe hypoglycemia in patients with diabetes. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,383.14 to AmerisourceBergen Drug Corp for the supply of Gvoke HyperPen 2-Pack 1 mg/0.2 ml auto-injectors on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Gvoke HyperPen is an emergency glucagon auto-injector used to treat...
- The Defense Logistics Agency awarded a $2,558.24 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for Gvoke HypoPen 1-pack 1 mg/0.2 ml auto-injectors, with an ultimate completion date of December 8, 2025. The contract carries no set-aside designation and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. AmerisourceBergen, headquartered...